
Sotagliflozin (Inpefa) is an orally administered dual SGLT1/2 inhibitor that reduces the risk of death due to heart failure.

Sotagliflozin (Inpefa) is an orally administered dual SGLT1/2 inhibitor that reduces the risk of death due to heart failure.

Arexvy shows efficacy in helping protect adults aged 50 to 59 years with an increased risk for respiratory syncytial virus lower respiratory tract disease.

A critical aspect of National Prescription Drug Take Back Day is the focus on Naloxone training.

Semaglutide was found to be the most effective drug for weight loss, but the benefits may not outweigh the cost associated with treatment.

The drug’s mode of action is different than other types of corticosteroids because it’s based in the differential effects on glucocorticoid and mineralocorticoid receptors.

Pharmacists can leverage their own identities to advocate for happier, healthier individuals within communities of different ethnic and socioeconomic backgrounds

From finding mentors to maintaining a balanced lifestyle, these insights will empower students to navigate the ever-evolving world of pharmacy.

Confident pharmacists have traits that highlight their professionalism and effectiveness in their roles, while avoiding behaviors that could undermine the quality of their work.

A weekly dose of injectable lecanemab-irmb (Leqembi) could allow patients with Alzheimer disease to receive the drug at home instead of visiting an infusion center twice per month.

Long lasting weight reduction was reported in individuals that were treated with tirzepatide with diet and exercise, compared to placebo.

Collaborating with patient advocacy organizations offers pharmacy students a unique opportunity to make a meaningful impact in health care.

BMS-986278 (Bristol Myers Squibb) is a potential first-in-class treatment for progressive pulmonary fibrosis and idiopathic pulmonary fibrosis.

Patients with HIV who were resistant to treatment with lenacapavir (Sunlenca; Gilead Sciences Inc) were found to have inadequate adherence to optimized background regimen or did not have a fully active antiretroviral.

Rimple Gabri, PharmD, a pharmacist with Giant Pharmacy for nearly 3 decades, shares her journey into the pharmacy profession.

Jack Mozloom, vice president of Public Affairs at the National Community Pharmacists Association (NCPA), speaks with Matt Seiler, general counsel at NCPA, about the current PBM litigation at the 2023 NCPA Convention.

Nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) is a monoclonal antibody approved to prevent against respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants under 8 months of age born during or entering their first RSV season.

Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.


Risk of long COVID was 3 times higher in those who had pre-existing conditions and a short sleep duration, compared to those with no pre-existing conditions and adequate sleep.

mRNA-1083 is an investigational combination vaccine designed to prevent influenza and COVID-19.

Jessica McMakin, PharmD, and Marina Mangham, CPhT, enjoy providing personalized service to their local community

Vanessa Campbell, PharmD, the director of Clinical Pharmacy at UPMC Health Plan, discusses her role and responsibilities, which include managing a team of pharmacists involved in patient outreach and clinical disease state management.

Innovative experiential learning can provide students with skills necessary to launch successful careers, keeping the pharmacy profession trusted by patients.

Infliximab-dyyb (Zymfentra; Celltrion USA) is a subcutaneous treatment for the maintenance treatment of adults with moderately to severely active ulcerative colitis and Crohn disease.

RSV can create a problematic infection among children 12 months of age or younger, older adults, and in patients with immunocompromised conditions.

Thrifty White has created a newsletter sharing the impacts their pharmacists have on patients, including one pharmacist who recognized stroke symptoms and was able to get the patient help.

Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.

This marks the first time that experts have defined cardiovascular-kidney-metabolic syndrome, including the overlap of cardiovascular disease with kidney disease, type 2 diabetes, and obesity.

